Episode Details
Back to Episodes
EULAR 2025 - Day 5 podcast
Episode 1340
Published 11 months, 2 weeks ago
Description
Biologic Switching in PsA
Decoding Difficult to Treat PsA
Deucravacitinib in Psoriatic Arthritis: A New Oral Option with Dual Impact
GLP 1 Receptor Agonists in axSpA Patients
Jekyll and Hyde: which RA-ILD is it?
RA treatment: A Constant State of Evolution